No Cover Image

Journal article 76 views

Dapagliflozin is associated with improved glycaemic control and weight reduction at 44 months of follow-up in a secondary care diabetes clinic in the UK / Natasha Shrikrishnapalasuriyar; Ayesha Shaikh; Aliya Mohd Ruslan; Giselle Sharaf; Maneesh Udiawar; David E. Price; Jeffrey Stephens

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume: 14, Issue: 3, Pages: 237 - 239

Swansea University Author: Jeffrey, Stephens

  • Accepted Manuscript under embargo until: 26th March 2021
Published in: Diabetes & Metabolic Syndrome: Clinical Research & Reviews
ISSN: 1871-4021
Published: Elsevier BV 2020
Online Access: Check full text

Tags: Add Tag
No Tags, Be the first to tag this record!
Keywords: Dapagliflozin; SGLT2 inhibitor; HbA1c; Cardiovascular
Issue: 3
Start Page: 237
End Page: 239